This elevated BACE-1 activity suggests a shared molecular pathway between T2DM and AD, potentially explaining the higher risk of cognitive decline and neuronal dysfunction observed in T2DM patients, as Aβ accumulation is central to both conditions [40,41,42]. The gene discussed is BACE1; the disease is type 2 diabetes mellitus.